Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: Cross‐sectional results of a German multicentre observational study (PROSa)

The Health-Related Quality of Life of Sarcoma Patients and Survivors in Germany—Cross-Sectional Results of a Nationwide Observational Study (PROSa)

(2020) Martin Eichler et al.   Cancers

Cognitive impairment and treatment effects among gastrointenstinal stromal tumor survivors: Results of a large online survey.

(2019) Robert J. Ferguson et al.   JOURNAL OF CLINICAL ONCOLOGY

Current State of Sarcoma Care in Germany: Results of an Online Survey of Physicians

(2019) Martin Eichler et al.   Oncology Research and Treatment

Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†

(2018) P G Casali et al.   ANNALS OF ONCOLOGY

Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia

(2018) Ehab Atallah et al.   BMC CANCER

Strengthening health data on a rare and heterogeneous disease: sarcoma incidence and histological subtypes in Germany

(2018) Meike Ressing et al.   BMC PUBLIC HEALTH

General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States

(2018) S. Nolte et al.   EUROPEAN JOURNAL OF CANCER

The Use of The Eortc Item Library To Supplement Eortc Quality of Life Instruments

(2017) D Kulis et al.   VALUE IN HEALTH

Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice

(2017) Margherita Nannini et al.   Therapeutic Advances in Medical Oncology

Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust

(2016) Johannes M. Giesinger et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Prevalence, Impact, and Correlates of Severe Fatigue in Patients With Gastrointestinal Stromal Tumors

(2016) Hanneke Poort et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional study

(2014) Sasja F Mulder et al.   BMC CANCER

Systematic review of the side effects associated with tyrosine kinase inhibitors used in the treatment of gastrointestinal stromal tumours on behalf of the EORTC Quality of Life Group

(2014) Samantha C. Sodergren et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Messung des sozioökonomischen Status in der Studie „Gesundheit in Deutschland aktuell“ (GEDA)

(2012) T. Lampert et al.   Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz

Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project

(2012) C.A. Stiller et al.   EUROPEAN JOURNAL OF CANCER

Evidence-Based Guidelines for Determination of Sample Size and Interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30

(2010) Kim Cocks et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

(2009) Ronald P DeMatteo et al.   LANCET

Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support

(2008) Paul A. Harris et al.   JOURNAL OF BIOMEDICAL INFORMATICS